Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
about
RNA vaccines in cancer treatmentRegulation of apoptosis at cell division by p34cdc2 phosphorylation of survivinSanguinarine suppresses prostate tumor growth and inhibits survivin expressionProteolytic cleavage of Livin (ML-IAP) in apoptotic melanoma cells potentially mediated by a non-canonical caspaseUVB-induced apoptosis drives clonal expansion during skin tumor developmentSurvivin: a unique target for tumor therapyImmune-phenotypical markers for the differential diagnosis of melanocytic lesionsHuman survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathwaySurvivin as a target for new anticancer interventionsTargeting survivin in cancer therapyCancer gene therapy using a survivin mutant adenovirusInhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-RasLocalization, dynamics, and function of survivin revealed by expression of functional survivinDsRed fusion proteins in the living cell.Expression and prognostic significance of survivin in de novo acute myeloid leukaemia.Proliferation, apoptosis, and survivin expression in a spectrum of melanocytic nevi.Polymorphisms in the survivin promoter are associated with age of onset of ovarian cancerDifferential regulation of survivin expression and apoptosis by vitamin D3 compounds in two isogenic MCF-7 breast cancer cell sublinesMolecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivityCharacterization of the 12C4 survivin monoclonal antibody and insight into the expression of survivin in human adult tissues.Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.Loss of nuclear receptor RXRα in epidermal keratinocytes promotes the formation of Cdk4-activated invasive melanomas.Development of replication-competent adenovirus for bladder cancer by controlling adenovirus E1a and E4 gene expression with the survivin promoterDrug-resistance in human melanoma.Survivin and escaping in therapy-induced cellular senescence.Inhibition of melanoma tumor growth in vivo by survivin targeting.Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases.Survivin an important determinant for prognosis in adult T-cell leukemia: a novel biomarker in practical hemato-oncology.Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study.Apoptosis in cancer: from pathogenesis to treatment.Theranostic properties of a survivin-directed molecular beacon in human melanoma cells.Survivin, versatile modulation of cell division and apoptosis in cancer.A phase 2, multicenter, open-label study of sepantronium bromide (YM155) plus docetaxel in patients with stage III (unresectable) or stage IV melanomaMitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol.Effects of JC virus infection on anti-apoptotic protein survivin in progressive multifocal leukoencephalopathy.Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.Survivin: a bifunctional inhibitor of apoptosis protein.Transgenic expression of survivin in keratinocytes counteracts UVB-induced apoptosis and cooperates with loss of p53Regulators of apoptosis: suitable targets for immune therapy of cancer.Tissue biomarkers for prostate cancer radiation therapy.Role of nuclear factor-kappa B in melanoma.
P2860
Q21296852-28A27208-B0E3-4391-90CA-73FEA45C19DDQ24290497-8339CCA9-CD63-4F51-894E-AFE68FD81CFAQ24628733-4EE56FD5-A2FF-4D61-BCCC-E9E54F13CEF3Q24656141-8FB3DD1C-B119-49E8-9918-D75D3D98AAE5Q24656167-431DD3DE-0134-4EA1-B829-6D93CD8A480FQ26747332-3EE85997-503D-47A8-BA9C-54B1F4812A9AQ26776090-7A0EA06B-D187-4FE6-965F-81551E66356BQ28215330-41519F02-7C0B-4046-98A5-DCE20D045093Q28257235-397875FF-D2C3-4825-A28C-E3331C5A82EFQ28273083-DE0C54B2-7802-47AD-AA89-F0F8703A5050Q28360690-8B44E7D2-6C64-4150-B937-ACEDF8E996DDQ28581092-2E02974C-10EA-4DC1-AB4B-C5D6E47DC8CEQ30881604-69390C81-185E-4807-9BBD-DDE1A4E8353DQ33181478-617F746C-DA28-42CC-945D-47FE6F0FE9D8Q33211038-178C6537-3133-45DA-BA6F-006398A9384FQ33572996-669FA6C5-A332-4921-9E76-24DC864D99B5Q33646953-3B3834FA-6951-45A2-A85F-BC5A767F32BFQ33676987-67FDB021-89E9-41CC-AB1B-BC027254E596Q33677012-3E7F78C1-E0DF-4FF1-8EB7-D5D9187C4963Q33887196-DD9E1AB8-E7FD-4059-9934-6D3EBB5F9D67Q34130042-6302D432-CC32-4F89-AB19-06AEC059901FQ34221639-A21CD1E4-EF7E-4364-8925-D4439B88EE7CQ34321923-31AEB435-E69F-4CC5-8F91-574B96133C3FQ34400375-38FB5D23-3D73-4C3F-937B-E4777B064928Q34623127-E4AB97C7-530B-49CA-A9EB-4EB0C9B1AAE8Q34802840-734E2238-942F-4743-9EB3-E5FAE025310BQ35076228-FA716C67-0037-4646-8BDB-0FF9EE12484EQ35083250-C01BB34F-977F-4109-979D-C2B98163A066Q35397889-41DD84FB-EE9A-462A-BE29-FA22BD52300BQ35515042-8C4E1476-471D-4B4F-B30B-856B06C17CD1Q35591693-D5E8F0A9-193C-4A8D-9602-63ED555655E2Q35602111-106BDD15-D517-43AB-930F-DC7E1BC3C0E9Q35649837-4FEF42D2-E7F7-44FE-A66C-7DA2D4223C63Q35691615-6A4EB310-2AA1-4AC6-AFE8-3E86AC9D99B2Q35842152-8F8DC612-2362-4ACA-944C-15142B1AA6AEQ35959085-12F19E6C-78E9-48FB-B99B-5FDD1714018BQ36042009-CDBE5A09-858D-49CB-B141-13AF7DF0017EQ36111911-C81FC310-3379-47DD-A338-94B8296D0917Q36141341-C97ED8F5-4657-472E-819F-EBEBC55E878AQ36178379-16329988-BEBD-4C45-B6D0-8A9F0213E6C8
P2860
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
@en
type
label
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
@en
prefLabel
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
@en
P2093
P1476
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
@en
P2093
P304
P356
10.1046/J.1523-1747.1999.00776.X
P407
P577
1999-12-01T00:00:00Z
P5875
P6179
1043293860